Serum Lactadherin as a Diagnostic Biomarker in Hepatitis C Virus Cirrhotic Patients with and without Hepatocellular Carcinoma - Egyptian Knowledge Bank - troweb

353881

Serum Lactadherin as a Diagnostic Biomarker in Hepatitis C Virus Cirrhotic Patients with and without Hepatocellular Carcinoma

Article

Last updated: 03 Jan 2025

Overview Similar Items

Article

Serum Clusterin as a Diagnostic Tool for HCV Related Hepatocellular Carcinoma

Article

Study of Serum Golgi Protein 73 Level as a Marker for Diagnosis of Hepatocellular Carcinoma

Article

Corroboration of Serum Apolipoprotein J (Clusterin) as a Biomarker for Evaluating Hepatocellular Carcinoma

Article

Serum MiRNA-122 as a Diagnostic Marker in HCV Related Liver Cirrhosis

Article

Transthyretin as a Novel Biomarker for Diagnosis of Hepatocellular Carcinoma in Cirrhotic Patients

Article

Serum biomarkers of hepatocellular carcinoma in patients with liver cirrhosis: a narrative review

Article

Serum Thioredoxin as a Diagnostic Marker for Hepatocellular Carcinoma in Cirrhotic Hepatitis C Patients

Article

SERUM LEVEL OF HEPCIDIN IN CIRRHOTIC PATIENTS AS A MARKER FOR HEPATOCELLULAR CARCINOMA

Article

Golgi Protein 73 as a Diagnostic Tool for Hepatocellular Carcinoma in Cirrhotic Hepatitis C Patients

Article

Role of Serum Midkine Level as a Diagnostic Biomarker for Very Early and Early Hepatocellular Carcinoma